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Graphical abstract  
 
 
 
Abstract 
The mechanism of polycation cytotoxicity and the relationship to polymer molecular weight 
is poorly understood. To gain an insight into this  important phenomenon a range of newly 
synthesized uniform (near monodisperse) linear polyethylenimines, commercially available 
poly(L-lysine)s and two commonly used PEI-based transfectants (broad 22 kDa linear and 25 
kDa branched) were tested for their cytotoxicity against the A549 human lung carcinoma cell 
line. Cell membrane damage assays (LDH release) and cell viability assays (MTT) showed a 
strong relationship to dose and polymer molecular weight, and increasing incubation times 
revealed that even supposedly “non-toxic” low molecular weight polymers still damage cell 
membranes. The newly proposed mechanism of cell membrane damage is acid catalysed 
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hydrolysis of lipidic phosphoester bonds, which was supported by observations of the 
hydrolysis of DOPC liposomes. 
 
Keywords: Cytotoxicity, Gene therapy, Hydrolysis, Molecular weight, MTT assay, 
Phospholipids. 
 
1. Introduction 
Polycations are materials that find application as delivery vectors in the field of DNA and 
RNA based therapies, because they condense polyanionic nucleic acids. This is a field with 
enormous promise, but one that has failed to achieve its full potential despite great clinical 
interest; mostly due to the toxicity of the polycationic carriers.(Behr, 2012; Gary et al., 2007; 
Pack et al., 2005) Further problems arise due to the fact that polymeric transfection methods 
require a large excess of polycations, which is not associated with the poly(nucleic 
acid),(Boeckle et al., 2004; Dai et al., 2011; Yue et al., 2011) and this present major 
limitations on in-vivo transfection due to different trafficking of the two populations.  
Polyethylenimine (PEI) is a cationic polymer which is commonly available with branched 
and linear structures, and has been synthesised in hairy, comb and cyclic structures. The 
branched structure is synthesised via the aqueous cationic polymerisation of aziridines, whilst 
the linear form is typically synthesised by the hydrolysis of a poly(2-oxazoline).(Monnery 
and Hoogenboom, 2015) Poly(L-lysine) is also commonly available via the ring-opening 
polymerisation of N-carbobenzoxy- L-lysine-N-carboxy anhydride.(Fasman et al., 1961) 
Since these polycations are some of the most frequently used in cell transfection, this work 
concentrates on assaying these materials. 
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The mechanism of cytotoxicity of polycationic materials, such as PEI, is a poorly 
understood matter.(Parhamifar et al., 2010) It is known that polycationic materials do not 
produce a apoptotic response, but rather cell death is due to necrosis,(Fischer et al., 2003) and 
that a variety of organelles are damaged. (Grandinetti et al., 2011; Grandinetti et al., 2012; 
Moghimi et al., 2005) The mechanism of the necrotic damage is not yet understood. Here we 
aim to investigate the effect of the properties of the polymer on cell membrane damage.   
There is a significant body of evidence that polycations open pores in cellular membranes. 
Banaszak-Holl and coworkers have shown that a wide variety of cationic macromolecules 
open pores in a supported phospholipid bilayers.(Hong et al., 2004; Hong et al., 2006; 
Leroueil et al., 2008; Mecke et al., 2005) Poration of the cells is a common way of 
transfecting cells, with various physical methods (electroporation etc.) and chemicals such as 
surfactants allowing polynucleic acids to simply diffuse into the cells.(Hapala, 1997) 
However, commonly used polycations such as PEI and PLL should not act as surfactants. 
It has been shown that the presence of uncomplexed polycation is responsible for the cell 
damage, but without their presence there is limited transfection.(Boeckle et al., 2004; 
Fahrmeir et al., 2007; Hanzlikova et al., 2011; Yue et al., 2011)Kichler et al. reported that 
PEI has no effect on cell membranes.(Kichler et al., 2001) However, the underlying 
experiments were carried out in citrate buffer, and the PEI was hence sequestered into an 
uncharged PEI-citrate complex(Eberhardy et al., 2009), so no free polymer was present. 
The effect of cationic polymer molecular weight on the cytotoxicity is poorly understood. 
Fischer et al. claim that higher molecular weight materials are more toxic,(Fischer et al., 
2003) but this is based on a rather random selection of cationic polymers as only one 
molecular weight of a range of different polymers is assayed and compared. Long et al. 
performed a systematic survey of the toxicity of poly(N,N-dimethylaminoethyl methacylate)s, 
but unfortunately the lowest molecular weight assayed (43 kDa) was so toxic that no 
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relationship can be discerned, although toxicity was clearly due to membrane lysis.(Layman 
et al., 2009) Two groups (Coll et al. and Wurm et al.) have independently fractionated a 
commercial broadly-polydisperse linear PEI (l-PEI) and assayed the individual fractions for 
transfection efficacy. They both reported that fractions below 4 kDa show little transfection 
activity and little toxicity, and fractions above 20 kDa show little activity but high toxicity, 
with a maximum transfection efficiency at ca. 15 kDa.(Falco et al., 2009; Kadlecova et al., 
2012) However, neither group performed an LDH or similar assay to assess the effect of the 
molecular weight on cell membrane disruption. Boe et al. assayed a limited range of 
commercial PEI samples of both linear and branched structures on osteosarcoma cells, with 
mitochondrial activity measured by (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) (MTS) after 24 h exposure. 
However, the limited range of materials (i.e. no polycations between 2.5 and 25 kDa) and 
lack of LDH or similar assays make further interpretation difficult.(Boe S, 2008) In none of 
these cases the degree of cell membrane disruption has been assessed (i.e. by the lactose 
dehydrogenase assay), and since the toxicity is clearly due to the disruption and poration of 
cellular membranes this is clearly a major gap in our knowledge, which will be addressed in 
the current work. 
The mechanism by which polycations induce pores on cellular membranes remains 
obscure, and essentially two reasonable models exist: either the polycations act as a 
surfactant(Vaidyanathan et al., 2016) or as a proton transfer catalyst.(Seddon et al., 2009) In 
the latter, the polycations acts as a proton transfer catalyst that could lead to the hydrolysis of 
the phospholipids and changes in the curved elastic stress of the membrane. This induces the 
formation of inverted hexagonal phases in the lipid bilayer (“pores”) and phase separation of 
lysophospholipids which form blebs, this being demonstrated for low molecular weight 
cationic materials.(Baciu et al., 2006; Casey et al., 2014; Casey, 2011; G.C. Shearman and 
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Templer, 2007) The latter requires the cationic polymer to stabilise a pore, and thus remain 
localised in the pore. This has never been observed, although the surfactant effect may 
explain poration by amine functionalized silica or gold nanoparticles, which has been 
observed by Banaszak-Holl and coworkers. 
The hypothesis of this work is that the toxicity of polycations increases with molecular 
weight (assuming the same structure and architecture), and is due to a greater degree of 
membrane disruption. To test this a systematical series of l-PEI covering a broad molar mass 
range has been synthesized (Monnery et al., 2015) and tested for mitochondrial activity and 
cell membrane damage in the A549 cell line, in comparison to 25 kDa hyperbranched  PEI 
(b-PEI) and a series of poly(L-lysine)s (PLL). To address the postulated membrane disruption 
by either hydrolysis or surfactant mechanism, experiments were undertaken to evaluate the 
hydrolysis of 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) in presence of PEI by 
HPLC.  
 
 
2. Materials and Methods 
2.1. Materials 
Calcium hydride (93%), 2-ethyl-2-oxazoline (99%), methyl tosylate (98%), dimethyl 
sulfoxide (99%), thiazolyl blue tetrazolium bromide (98%), various poly(L-lysine)s, 1,2-
Dioleoyl-sn-glycero-3-phosphocholine, various poly-L-lysines and 25 kDa hyperbranched 
PEI  were purchased from Sigma-Aldrich. Water used was purified by reverse osmosis to 18 
MΩ (Barnstead Nano-pure). Hydrochloric acid (37%), sodium hydroxide (99%+, pellets), 
DCM (99.8%+) and diethyl ether (99.8%+) were purchased from VWR (Lutterworth, UK). 
Phosphate buffered saline, DMEM (Glutamax), OptiMEM and fetal calf serum were 
purchased from Gibco (Thermo Fisher Scientific Inc., Loughborough, U.K.). LDH release 
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assay were purchased from Promega (Madison, WI, U.S.A.) under the name “CytoTox 96® 
Non-Radioactive Cytotoxicity Assay”.   
Acetonitrile was stirred over calcium hydride overnight and then refluxed (2 h) before 
being distilled under argon into a Schlenk equipped two necked round bottom flask. 2-Ethyl-
2-oxazoline was stirred over calcium hydride overnight and then refluxed (2 h) before being 
distilled onto activated 3Å molecular sieves (activated by heating > 300°C for > 1 h under < 
1 mbar vacuum, cooling and backfilling with dry nitrogen). Nitrogen gas (BOC) and argon 
(BOC pureshield) were dried through sodium hydroxide and self-indicating silica gel. 
Syringe filters (0.22 μm polysulfonate filter with polypropylene housing) were purchased 
from Fisher (Loughborough, UK). 
Standard glassware was used throughout. The polymerisation vessel was an oven dried two 
neck flask equipped with a tap (for addition of liquid reagents and sampling) and a condenser 
with an isolation tap connected to the Schlenk line via rubber tubing and was flame dried 
under vacuum before use. Liquid reagents were handled with vacuum dried gas-tight syringes 
(Hamilton, Bonaduz, Switzerland) using Schlenk technique. Glassware for hydrolysis to l-
PEI etc. was similar, although less rigorous procedures were adopted in light of the aqueous 
solvent. 
 
2.2. Instrumentation and polymer characterisation 
Polymers were analysed by Size Exclusion Chromatography (SEC) and Nuclear Magnetic 
Resonance Spectroscopy (NMR). The SEC was a Polymer Laboratories GPC-50 with 2x 
PLGEL MIXED-D (300 x 75 mm) columns and a guard column (50 x 7.5mm MIXED-D), 
using DMF (1% (v/v) triethylamine and acetic acid); poly(methyl methacrylate) (PMMA) 
standards were  used as calibrants. A sample of the crude reaction mixture was mixed with an 
equal volume of deuterated chloroform and analysed via 1H-NMR spectroscopy on a Bruker 
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DX-400 machine and the degree of conversion was determined by integrating the polymer 
backbone (δ = 3.1-3.8 ppm) and the two methylene peaks (4 and 5 position) of the oxazoline 
ring (δ ~ 3.8 and 4.1) using the equation: 
𝑝 =  
∑ 𝛿(𝑏𝑎𝑐𝑘𝑏𝑜𝑛𝑒)
∑(𝛿(𝑏𝑎𝑐𝑘𝑏𝑜𝑛𝑒) + 𝛿(𝑚𝑜𝑛𝑜𝑚𝑒𝑟 4′) + 𝛿(𝑚𝑜𝑛𝑜𝑚𝑒𝑟 5′))
 
A multi-angle light scattering DAWN EOS (Wyatt Technologies Corporation) was placed 
in series between the SEC column and the refraction index detector and used to determine 
ƉLS.(Shortt, 1994) 
Microplates were read on a Spectra Max 190 microplate reader (Molecular Devices, 
Sunnyvale, California) at the appropriate wavelength. Cell images were obtained with a Zeiss 
Vision KS400 system (Carl Zeiss, Gottingen, Germany). High-Performance Liquid 
Chromatography (HPLC) eluograms were recorded on an Agilent 1100 series with 
quaternary pump, diode array detector, evaporative light scattering detector (Polymer Labs 
PL-ELS 2100) and an incubated injector. The column was a 5 cm 5 μm C18 (Phenomenex, 
Macclesfield, U.K.) with the elution gradient 0 min water, 11 min acetonitrile, 12 min 
acetonitrile, 23 min methanol, 25 min methanol, 27 min water, 30 min water. All solvent 
changes were isocratic. Flow rate was 2.5 mL/min. 
 
2.2. Synthesis 
 
Polymerisation of 2-isopropyl-2-oxazoline and hydrolysis to l-PEI. The synthesis of 
these materials has been reported.(Monnery et al., 2015)  
 
Polymerisation of EtOx500. The polymerisation was carried out essentially as per the 
commercial product in-vivo jetPEI.(Adib et al., 2010) Into a two neck round bottom flask 
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with stirrer and reflux condenser was added 2-ethyl-2-oxazoline (5 mL, 4.75 g, 4.8 mmol), 
dry acetonitrile and a methyl tosylate stock solution in acetonitrile for a monomer to initiator 
(M:I)  ratio of 500 (17.85 mg MeOTs, 95.8 μmols in 10 mL acetonitrile). The mixture was 
refluxed under argon for 48 h, with a sample taken at 24 h (90% conversion by 1H-NMR 
spectroscopy) and quenched at 48 h (99.5% conversion) with a 5% sodium carbonate in water 
solution and left to reflux overnight before being extracted into dichloromethane. The organic 
phase was dried with anhydrous magnesium sulfate, filtered through paper and concentrated 
in vacuo before precipitating into 20 volumes of diethyl ether, filtering (P2 glass frit) and 
drying in vacuo yielded a slightly yellow powder E1 (4.2 g, 90%). The 1H-NMR spectrum 
was consistent with the literature.(Rivas and Ananías, 1987) 
1H-NMR (400 MHz, D2O) δ = 1.00 (br, 3H, CH2-CH3), 2.30 (br, 2H, (C=O)-CH2-CH3), 
3.46+3.54 (2x br, 4H, C(C=O)-CH2-CH2-) 
SEC: Mn = 24.4 kDa, Mm = 49.8 kDa, Mp = 61.8 kDa, ÐRI = 2.04, ÐMALS = 1.12 
 
Hydrolysis to l-PEI500. P(EtOx)500 (1.40 g, 14 mmol of repeat units) was dissolved in 6N 
hydrochloric acid (50 mL) and refluxed overnight at 120°C in an oil bath. The volatiles were 
removed in vacuo, the residue was dissolved in boiling water (50 mL) and made basic with 
sodium hydroxide (~ 1 g). On cooling the hydrate of L-PEI precipitated, was filtered (P2 
glass frit), washed with water (~ 1 L) until the filtrate was neutral and dried in vacuo 
overnight to yield a white powder. A sample (43.5 mg, 1 mmol) was placed in a HPLC vial 
and dissolved in propanoic anhydride (0.64 mL, 5 mmol, 5 equiv), sealed and heated to 65°C 
overnight, cooled, quenched with water (1 mL) and the volatiles removed. The residue was 
analysed by SEC and showed no significant change in molecular weight distribution 
compared to the starting polymer, showing main chain stability during hydrolysis. The 
remainder of the product was dissolved in boiling water (1 mL) and 37% hydrochloric acid (1 
10 
 
mL) was added. The volatiles were removed in vacuo to yield PEI500 as a white powder 
(0.97 g, 86%). The 1H-NMR spectrum was consistent with the literature and showed 99.6% 
hydrolysis. (Adib et al., 2010; Saegusa et al., 1972) 
1H-NMR (400MHz, D2O): δ= 3.5 (br, 4H, -CH2-CH2-NH2Cl-)  
13C NMR (101MHz, D2O): δ= 44.0 (-CH2-CH2-NH2Cl-). 
 
Branched PEI hydrochloride. Freebase hyperbranched PEI (0.64 g) was dissolved in 6N 
hydrochloric acid (25 mL) and stirred for 1 h. Volatiles were removed in vacuo to yield 1.12 
g (100%) of slightly yellow crystals. 
1H-NMR (400MHz, D2O): δ= 2.7-3.9 (br m, 4H, -CH2-CH2-NH2Cl-), 7.4-8.3 (br m, 
various amines), 
13C NMR (101MHz, D2O): δ= 35.5 (methylene adjacent to 1⁰ amine in 1⁰-3⁰ diad), 37.0 
(methylene adjacent to 1⁰ amine in 1⁰-2⁰ diad), 43.5 (methylene adjacent to 2⁰ amine in 2⁰-3⁰ 
diad), 44.5 (methylenes inside 2⁰-2⁰ diad), 46.5 (methylene adjacent to 2⁰ amine in 1⁰-2⁰ 
diad), 49.0 (methylene adjacent to 3⁰ amine in 2⁰-3⁰ diad), 50.0 (methylene adjacent to 3⁰ 
amine in 1⁰-3⁰ diad) 
 
2.3. Investigation in the effect of molecular weight on cell membrane viability 
A549 cells (European Collection of Cell Cultures) were cultured in supplemented DMEM 
(10% v/v FCS, 1% 5,000 units/mL Penicillin/ 5,000 units/ mL Streptomycin). Subculturing 
and the preparation of plates are described in the supplementary information. 
Polycation stock solutions were made at 1 mg/mL in serum free OptiMEM (~ 25 mL) and 
filter sterilised (0.22 μm polysulfonate syringe filter), discarding the first 5 mL of filtrate (to 
remove filter adsorption effects). After equilibrating at room temperature for at least 24 h (to 
stabilise pH) serial dilutions were made with OptiMEM for final polycations concentrations 
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of 1000 μg/mL, 100 μg/mL, 10 μg/mL and 1 μg/mL. The media in the experimental wells 
was carefully removed by hypodermic syringe and replaced with 100 μL of serum free 
OptiMEM. Once all wells had undergone the media change the process was repeated, adding 
the appropriate polycation solution. Wells were left for negative control (no cells), negative 
control (lysed cells), positive control (no polycation, vehicle control) and dilution control (no 
cells, but lysis buffer added). The plates were then returned to the incubator. One h before 
experimental readout 10 μL of Lactate Dehydrogenase (LDH) lysis buffer (1.1% triton x-
100) was added to the positive control and dilution control wells. This plate is designed plate 
A. 
The procedure for LDH/MTT experiments was thus; after the required incubation time 
(generally 4 h) the supernatant was carefully removed from each well of plate A with a 
multichannel pipette set at 150 μL and transferred to a 96 well v-bottom plate (plate B). The 
media of plate A was replaced with 100 μL complete media, 20 μL of MTT solution (5 
mg/mL 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide in PBS) was added and 
the plate returned to the incubator for 5 h. Plate B was sealed with parafilm and centrifuged 
(241 g, 4 min), then 50 μL of the supernatant was transferred to a 96 well flat bottom plate 
(plate C). 50 μL of reconstituted LDH was added to all wells and the plate wrapped in 
aluminium foil and placed in the dark. After exactly 30 min 50 μL stop solution (1 M acetic 
acid) was added to each well. The absorbance at 490 nm was read on an ELISA plate reader. 
Excess LDH release was calculated from plate B as follows: 
𝐿𝐷𝐻 𝑅𝑒𝑙𝑒𝑎𝑠𝑒 =
𝐴490 (𝑒𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑎𝑙) −  𝐴490 (𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒)
𝐴490 (𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒) − 𝐴490 (𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒)
 
Where A490 = absorbance at 490 nm, (experimental) is the observed result, (negative) is the 
average result of 6 vehicle control wells, and (positive) is the average result of 6 control wells 
lysed with 1.1% Triton X-100 1 h prior to the addition of the assay reagent. 
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For MTT plate A was centrifuged (241 g, 4 min), the supernatant removed carefully, 
DMSO (100 μL) was added and the plate returned to the incubator. After 30 min the 
absorbance at 570 nm read on an ELISA plate reader. Viability was calculated from plate A 
as follows: 
𝑀𝑖𝑡𝑜𝑐ℎ𝑜𝑛𝑑𝑟𝑖𝑎𝑙 𝐴𝑐𝑡𝑖𝑣𝑖𝑡𝑦 =
𝐴570 (𝑒𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑎𝑙) −  𝐴570 (𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒)
𝐴570 (𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒) − 𝐴570 (𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒)
 
Where absorbance values are analogous to those in the LDH assay.  
Some MTT assays were conducted without LDH, and were performed as above without the 
LDH component.  
IC20 and IC50 values were computed by fitting a linear model to the measurements and the 
logged doses for each polymer at each time-point. This linear model was used to predict the 
doses needed to get 50% and 20% toxicity, along with the 95% upper and lower bounds for 
these values determined using the LINEST function of Microsoft Excel to determine Δy. 
 
2.4. Studies of Phospholipid Hydrolysis 
DOPC liposomes were formed by placing 200 μL of a 10 mg/mL DOPC in chloroform 
solution into a 5 mL round bottom flask, and removing the volatiles in vacuo. The DOPC was 
re-suspended in water and sonicated for 1 h at 40°C to yield liposomes. To 0.5 mL of a 2 
mg/mL DOPC liposome suspension as added 0.5 mL of 2 mg/mL PEI358 (both in water and 
prewarmed to 37°C). The mixture was incubated at 37⁰C in a temperature controlled HPLC 
sample chamber and samples were taken every 32 min (or 4 h) by the HPLC autosampler. 
 
3. Results and Discussion 
3.1. Selection and Synthesis of Polymeric Materials 
3.1.1. Synthesis and Characterisation of l-PEI 
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The PEI500 sample was synthesised as per an existing patent(Adib et al., 2010), so as to 
give a material comparable with the commercial material. It was of interest whether the fairly 
broad molecular weight distribution observed for the precursor poly(2-ethyl-2-oxazoline) 
would be preserved in the synthesised l-PEI. Hence re-acylation of the PEI freebase was 
conducted, and the molecular weight distribution was indeed preserved (see Fig. S1), which 
was consistent with a recent report.(de la Rosa et al., 2014) This is at odds with the usually 
proposed mechanism of chain transfer, which postulates that branch points will be 
hydrolysed.(Litt et al., 1975; Warakomski and Thill, 1990) 
Broad l-PEI500 was synthesised by hydrolysis in 16.5% (v/v) hydrochloric acid (degree of 
hydrolysis (99.6%), the volatiles removed, re-dissolved in boiling water (ca. 5 mL) and made 
basic with NaOH. The freebase PEI crystallised as the temperature fell below ~ 60°C and the 
PEI was washed with copious water until the filtrate was neutral.(Lambermont-Thijs et al., 
2009) Each freebase PEI was converted back into the hydrochloride salt by dissolving in 1 
mL of boiling water followed by the addition of 1 mL conc. hydrochloric acid, and followed 
by the removal in vacuo of volatiles.   
The dispersity value reported in the patent literature was obtained via multi-angle light 
scattering. The SEC system employed here was equipped with such a device, and the 
observed ƉMALS was 1.12 (see figure S2), which is comparable to the commercial material. 
(Adib et al., 2010; Shortt, 1994)  
The synthesis of the five narrow l-PEI polymers has been previously described.(Monnery et 
al., 2015)  
 
3.1.2. Comparator Polycations 
Comparisons between different polycations are complicated by the fact that the common 
nomenclature used for PEI and PLL are different. PEI molecular weights are reported as the 
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freebase (despite the linear form being invariably used as a hydrochloride salt), whilst PLL 
molecular weights are reported including the counter-ion (invariably a hydrogen bromide 
salt). For this reason in this paper we have decided to refer to the polymers by their DPw, 
thereby avoiding this confusion. 
Branched 25 kDa PEI (b-PEI) and a range of commercially available PLL with similar 
molecular weights and were also chosen as comparators. The b-PEI was chosen due to its’ 
common use in gene therapy studies, and hydrochloride salt as well as the freebase was 
investigated. The PLL was chosen as a commonly used transfectant available in a range of 
molecular weights. However due to the different pKa values, the protonation states of the 
polymers will be different.  
The pKa of linear PEI is 7.2-7.9 (Brissault et al., 2003). For branched PEI von Harpe et al. 
have measured the 25 kDa branched PEI itself and report a pKa of 8.4.(Suh et al., 1994; von 
Harpe et al., 2000) The pKa of PLL is that of lysine (10.5) and the pKa is not dispersed, 
unlike PEI.(Frey and Corn, 1996) This means that using the Henderson-Hasselbalch equation 
it can be determined that at pH = 7.4 approximately 55% of linear PEI secondary amines are 
protonated, ~90% of branched PEI amines and effectively all the PLL amines are protonated. 
The total number of charges per polymer can thus be determined by multiplying through by 
the DPw. This correlates with the observation that branched PEI complexes DNA to a greater 
extent than linear PEI, due to the higher charge density of b-PEI.(Itaka et al., 2004) The 
number of protonated amines per polymer is shown in table 1. 
 
3.2. Effect of polycations’ molecular weight on membrane integrity and cell viability. 
To determine whether polycations induced cell membrane disruption an LDH release assay 
was employed, which since it uses the supernatant only was multiplexed with an MTT assay 
by washing the cells in the culture well and supplying fresh media (see experimental 3.3). 
15 
 
This assay measures the quantity of a cytosolic enzyme released from the cell, which is 
proportional to cell membrane disruption. This assay therefore reports the formation of 
permanent pores, but not transitory ones. LDH release experiments in previous reports 
showed qualitatively that polycations induce cell membrane damage.(Fischer et al., 2003; 
Ryser, 1967) By using well defined polymers of different molecular weights it will be 
possible to detect trends and thus provide quantitative data. The polymers were assayed by 
LDH release. After a 4 h exposure of the cells to the polycations the LDH release was 
assessed and the results are shown in Fig. 1. 
 
Due to the relatively low toxicity of the smallest PEI cells were incubated with polymers 
for the 48 h and an LDH assay performed (Fig. 2). This exposure showed high levels of LDH 
release for all polycations at the 10 μg/mL concentration except PEI34 and PLL4. There is a 
drop in LDH “release” at the highest concentration due potentially to degradation of the 
released LDH. The data thus indicates that long-term exposure of cells with any PEI or PLL 
of significant molecular weight would be toxic. 
To compare the toxicity data, the 4 h results were converted to semi-logarithmic dose-
response curves and the line of best fit was converted into an IC20 and IC50 value by 
substitution of a linear data fit with 95% confidence intervals (Table 2). In the case of the low 
MW l-PEI it was concluded that IC20  and IC50 were much greater than 1000 μg/ml.   
PLL has been previously shown to lyse cell membranes(Hill et al., 1999) and has been 
reported to be more disruptive than l-PEI(Oku et al., 1986). Our current results confirmed this 
observation. Comparing, for example, PEI358 and PLL327, which have similar number of 
repeat units, for the 4h exposure experiment the PEI358 showed an IC20 4.6 times greater to 
PLL327, and an IC50 for the PEI that was above our measured range, whereas the IC50 of the 
PLL was low. This indicated that the order of toxicity was PLL > b-PEI > l-PEI. This is in 
16 
 
agreement with the charge density of the polymers, with the most charge dense polymers 
being the most toxic. 
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Mitochondrial activity was assayed by the MTT assay using A549 lung cancer cells. Multiple 
exposure times (4, 24 and 48 h) of the various polymers were undertaken (multiplexed with 
LDH) and the cells seeded at 10,000 cells/well 16 h before experimentation. At the lower 
exposure times there was consistently greater mitochondrial activity in all experimental wells 
than the negative control well, except when extremely high concentrations were used, which led 
to immediate cell death. This is an observed phenomenon, but is rarely commented upon. 
Problems with increased mitochondrial activity during MTT are known(Stockert et al., 2012), 
and Parhamifar et al. suggest extreme caution is required when using MTT for just this 
reason(Parhamifar et al., 2010). A common explanation is mitochondrial uncoupling due to pore 
formation, but evidence relies on isolated mitochondria, and not whole cells(Grandinetti et al., 
2011; Larsen et al., 2012). A simpler explanation could be that since polycations damage cell 
membranes, the cell is simply attempting to maintain homeostatis after sub-lethal damage, by 
upregulating respiration to provide energy to repair the damage.  
 
With 4 h incubation with polycations (seeded at 10,000 cells/well) the MTT assay showed the 
results presented in figure 3a. Experimental groups can be divided into a few that have suffered 
acute necrotic toxicity (the highest doses of the high MW polymers observed to disrupt cell 
membranes), and the majority which show mitochondrial activity values in excess of 100%, with 
the least toxic (by LDH) polymers showing an inverse relationship to that expected – higher 
exposure concentrations provoked greater mitochondrial activity. The trend continued at 24 and 
48 h (figures 3b and 3c), although it was less pronounced and at 48 h exposure with few 
experimental groups having greater than 100% mitochondrial activity. IC20/IC50 values are 
estimated in table 3 in analogous fashion to table 2. 
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The 4 h exposure of cells to polycations and the assessed LDH and MTT are plotted against 
each other in figure S4. Ideally, if the two assays are complementary there should be a 
correlation. In our case this was indeed observed, showing complementarity of the two assays 
(Fig. S4). This suggests that the major cause of toxicity is the disruption of cellular membranes. 
The fact that mitochondrial activity is preserved even with very significant (ca. 30%) LDH 
release shows that the cells can survive with major cell membrane damage when exposure to 
polycations is for short periods of time.  
 Cells were microscopically investigated, and micrographs of cells exposed to polycations for 
48 h at 10 μg/mL are shown in figure 4. The control wells (Fig. 4a) show the typical morphology 
of A549 cells. With exposure to low MW polycations (PEI65) some squibs and cell debris are 
visible, but cells show generally healthy morphologies (Fig. 4b). As MW of polycation increases 
e.g. for PEI136 treatments the cells become rounded and lysed cells are visible (Fig. 4c), further 
increases to PEI222 shows the majority of cells dead (fig. 4d), and at higher MW (PEI500) the 
vast majority of cells are lysed (Fig. 4e). PLL shows the same pattern (PLL327 shown in Fig. 
4f). The same squib like cell debris was observed within 30 min by Martinez et al. with 10 mM 
poly(allylamine hydrochloride).(Martinez et al., 2011) Since observations of these squibs have 
been made with PEI (both linear and branched), PLL and PAA it seems likely that this is a 
general feature of polycationic disruption of cell membranes. These squibs have also recently 
been observed for a variety of low molecular weight cationic amphiphiles(Casey, 2011). 
This data shows that even relatively small polycations, such as PEI65 and PLL71 can induce 
cytotoxicity in the long term, even if minimal toxicity is observed during a 4 h exposure (typical 
for a transfection experiment). Only the extremely low molecular weight materials (PEI34,PLL4 
and PLL71) were well tolerated  for 48 h, producing less than 25% LDH release, although excess 
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LDH release was still observed (fig. 2), and an apparent increase in mitochondrial activity (fig. 
3c) showed that the cells were being stressed. Some cell debris was visible with PEI34 indicating 
that the membrane was being disrupted, but the cells were able to repair themselves. 
 
3.3. Hydrolysis of phospholipids by l-PEI. 
A study was conducted to assess Baciu et al.’s claim that PEI hydrolyses phospholipids , with 
the acidic proton being the protonated amine  (Baciu et al., 2006). Control experiments showed 
no hydrolysis of DOPC by pure water at 37⁰C over a week. At 37⁰C PEI358 (which should be 
optimal for transfection) was mixed with DOPC at a ratio of 9.9 amines per DOPC (calculated to 
be the approximate ratio in a tissue culture well during transfection experiments). Hydrolysis was 
rapid, and apparently zero-order with respect to both reactants, and at the four h time point 
almost half of the DOPC had been hydrolysed (fig. 5). Initial experiments incubating a wide 
range of different MW PEI in identical conditions (figure S5) suggest a molecular weight effect, 
which will be the subject of further investigation. 
3.4. Suggested Mechanism of Poration 
There is a strong molar mass effect on the destruction of cellular membranes and the cells 
release blebs possibly without caspase upregulation. DOPC liposomes are hydrolysed by PEI, 
apparently in a molar mass related manner manner (Fig. S5), Baciu et al.’s hydrolysis theory 
appears supported by the available evidence. The issue of toxicity resolves into whether 
membrane hydrolysis is occurring more rapidly than the cells repair systems, or not. When 
hydrolysis is more rapid than repair this leads to eventual cell death by lysis of the membrane. If 
the rate of repair can counterbalance the lysis of membranes the material is tolerated with an 
observable increase in mitochondrial activity to power the repair.  
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We have previously suggested that hydrolysis can be used to explain endosomal release 
without resorting to hydrostatic pressure.(Monnery and Hoogenboom, 2015) In short the 
polycation-polyanion complex will fall apart when acidified if the pKa of the polycation is within 
the normal range of cells, and the released free polycations will subsequently hydrolyse the 
phospholipids to induce a pore in the endosome from within. It also raises a potential mechanism 
for internalization without endocytosis, and release via autophagy.  
 
4.0. Conclusions 
We set out to determine the relationship between the molecular weight of l-PEI (and related 
polycations) and cytotoxicity, a topic of much speculation but no unambiguous data to date. 
Assays of cell membrane damage and mitochondrial activity clearly showed a dose-response and 
importantly a molecular weight response. We have concluded that the cytotoxicity of polycations 
is directly related to molecular weight and pKa, with higher molecular weight and more cationic 
materials being more toxic. The disruption of cell membranes even by low MW polycations over 
time indicates there is no such thing as “non-toxic” polycations. Two theories of the mechanism 
of cellular membranes (hydrolysis and surfactant-effect) have been proposed in the literature, 
and our observations of cells and liposomes support the hydrolysis theory as first toxicity effect 
on the cell, as the predicted blebs are observed with cells and DOPC hydrolyses to MOPC and 
oleic acid in the presence of l-PEI dependent on the molecular weight of the polymer. The 
mechanism of toxicity appears, thus, to have as first step the hydrolysis of cellular phospholipids. 
This has implications on polymeric transfection and could provide a potential mechanism of 
cellular entry without endocytosis. 
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Supporting Information.  
Supporting information (MW analysis of PEtOx and PEI500, the effect of allowing cells to come 
to confluence and the correlation between MTT and LDH) is available in a separate document. 
This material is available free of charge via the Internet at http://pubs.acs.org. 
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Figure 1. LDH release assay on A549 cells after 4 h exposure. n=4+/-SD. Polymers information 
is provided at Table 1. 
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Figure 2. LDH release assay on A549 cells after 48 h exposure, n=4 +/-SD.  
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Figure 3. Mitochondrial activity assayed by MTT assay. A549 cells were seeded 16 h before 
exposure at 10,000 cells per well. Exposure times: (a) 4 h, (b)  24 h, (c) 48 h. n =  4 
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Figure 4. A549 cells imaged after 48 h incubation with 10 μg/ml polycations. (a). Untreated 
control. (b). PEI65 (c) PEI136 (d) PEI222 (e) PEI500 (f) PLL327. With increasing MW cells 
start shedding vesicles, rounding up and finally lysing. PLL shows the same morphologies. 
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Figure 5. Concentration (in μg/mL) of DOPC during hydrolysis with l-PEI358 at 37⁰C. 
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Table 1. Characteristics of polycations used in this study. Mass-average molecular weight (Mm) 
in kDa.  a. ultra narrow PEI  Ɖ <1.02, broad PEI Ɖ = 1.12, PLL Ɖ broad (Ɖ ca. 1.2),  b – 
literature values (Brissault et al., 2003; Suh et al., 1994; von Harpe et al., 2000), c – at pH = 7,4, 
determined from pKa and DPw, d – suppliers values. 
Name Structurea Mm DPw pKa
b 
No. of 
cationic 
charges 
per 
polymerc 
 
PEI34 
narrow linear 
PEI.HCl 
1.3 34 7.45 19 
 
PEI65 
narrow linear 
PEI.HCl 
2.8 65 7.45 36 
 
PEI136 
narrow linear 
PEI.HCl 
5.9 136 7.45 75 
 
PEI222 
narrow linear 
PEI.HCl 
9.8 222 7.45 122 
 
PEI358 
narrow linear 
PEI.HCl 
15.9 358 7.45 197 
 
PEI500 broad linear PEI.HCl 22.0 500 7.45 275  
PLL4 linear PLL.HBr 0.8 d 4 10.5 4  
PLL71 linear PLL.HBr 15.0 d 71 10.5 71  
PLL115 linear PLL.HBr 24.0 d 115 10.5 115  
PLL327 linear PLL.HBr 68.6 d 327 10.5 327  
b-PEI 
broad hyperbranched 
PEI freebase 
25.0d 580 8.4 522 
 
b-PEI.HCl 
broad hyperbranched 
PEI.HCl 
25.0d 580 8.4 522 
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Table 2. IC20 and IC50 values for LDH release of tested polycations with 95% confidence 
intervals. Concentrations in μg/mL. >1 = estimated 2000-5000 μg/mL, >>1 = estimated higher 
than 5000 μg/mL. 
  LDH 4 h LDH 48 h 
Material IC20 (95% CI) IC50 (95% CI) IC20 (95% CI) IC50 (95% CI) 
PEI34 >> 1,000 >> 1,000 173.5 (83.7-359.6) >> 1,000 
PEI65 >> 1,000 >> 1,000 2.6 (2.3-2.9) 54.2 (48.6-60.4) 
PEI136 >> 1,000 >> 1,000 4.1 (1.5-10.9) 48.6 (18.3-129.2) 
PEI222 1,209 (1,085-1,347) >> 1,000 3.3 (1.3-8.6) 27.2 (10.5-70.8) 
PEI358 23.3 (18.3-29.5) >> 1,000 3.4 (1.2-9.5) 24.6 (8.7-69.6) 
PEI500 12.2 (6.5-22.7) 163.9 (88.0-305.4) 3.1 (1.2-8.1) 30.3 (11.6-79.6) 
PLL4 >> 1,000 >> 1,000 362.4 (204.6-641.9) >> 1,000 
PLL71 65.8 (21.8-198.4) 1,215 (402.8-3,665) 21.3 (8.5-53.4) 103.9 (41.5-260.0) 
PLL115 13.0 (10.3-16.6) 183.6 (144.3-233.7) 6.2 (2.9-13.3) 40.0 (18.7-85.6) 
PLL327 4.5 (2.9-7.0) 31.1 (20.2-47.8) 4.3 (1.6-11.5) 28.5 (10.6-76.9) 
25b-PEI 4.1 (2.4-7.0) 28.9 (16.9-49.5) 3.9 (1.2-12.9) 20.6 (6.3-67.2) 
25b-
PEI.HCl 6.3 (4.2-9.5) 38.5 (25.3-58.4) 5.9 (2.8-12.4) 41.4 (19.6-87.1) 
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Table 3. IC20 and IC50 values for cell viability measured by MTT assay of tested polycations. Concentrations in μg/mL. >1 = 
estimated 2000-5000μg/mL, >>1 = estimated higher than 5000 μg/mL. 
  MTT 4 h MTT 24 h MTT 48 h 
Material IC20 (95% CI) IC50 (95% CI) IC20 (95% CI) IC50 (95% CI) IC20 (95% CI) IC50 (95% CI) 
PEI34 >> 1,000 >> 1,000 >> 1,000 >> 1,000 >> 1,000 >> 1,000 
PEI65 >> 1,000 >> 1,000 47.5 (19.3-116.7) 2,036 (828.6-5,000) 35.5 (17.1-73.6) 195.7 (94.3-406.2) 
PEI136 >> 1,000 >> 1,000 11.4 (5.1-25.6) 73.6 (32.7-165.5) 4.9 (2.9-8.2) 37.7 (22.2-63.8) 
PEI222 >> 1,000 >> 1,000 3.7 (2.7-5.0) 25.8  (19.0-35.0) 5.7 (3.2-10.0) 27.2 (15.4-48.0) 
PEI358 193.0 (85.7-0.435) >> 1,000 4.5 (2.7-7.3) 25.3 (15.3-41.8) 5.6 (3.1-10.0) 26.4 (14.7-47.4) 
PEI500 66.1 (22.6-193.6) 433.7 (148.2-1,270) 2.8 (1.6-5.1) 18.5 (10.2-33.5) 3.2 (1.7-5.8) 19.1 (10.4-35.2) 
PLL4 >> 1,000 >> 1,000 >> 1,000 >> 1,000 >> 1,000 >> 1,000 
PLL71 95.0 (29.0-310.6) 397.5 (121.6-1,300) 101.6 (23.3-441.5) 655.7 (150.9-2,849) 25.2 (4.4-142.9) 61.0 (10.8-346.2) 
PLL115 9.2 (5.0-17.2) 51.2 (27.5-95.4) 13.6 (7.5-24.5) 55.0 (30.4-100.0) 9.2 (3.8-22.3) 36.1 (14.9-87.3) 
PLL327 2.4 (0.4-12.5) < 1 8.3 (4.6-14.9) 35.8 (19.8-65.6) 10.6 (5.9-19.1) 41.1 (22.8-74.1) 
25b-PEI 17.3 (9.6-31.2) 105.8 (58.8-190.4) 7.1 (3.8-13.4) 32.4 (17.1-61.1) 7.6 (2.6-22.3) 32.1 (11.0-94.2) 
25b-
PEI.HCl 32.0 (18.3-56.2) 141.0 (80.3-247.4) 10.1 (4.7-21.7) 42.8 (20.0-91.8) 6.8 (3.8-12.4) 32.5 (17.9-59.1) 
 
